Mitral Stenosis Worsening in Pregnancy: Medical Management or Balloon Valvuloplasty Now?
Her valve area has moved from moderate to severe since this pregnancy began, and the team is weighing how far rate control and diuresis can carry her against a real, narrowing window for a safer procedure.
P.A., a 28-year-old woman, works as a pharmacy technician at the same hospital where she is now, at 24 weeks into her second pregnancy, becoming a patient in the cardiology clinic down the hall from where she usually fills prescriptions. Her first pregnancy, four years ago, was uncomplicated; her rheumatic mitral stenosis wasn't diagnosed until a year after that, worked up after a murmur was picked up on a routine exam and traced back to rheumatic fever she'd had as a child in another country, mild enough at the time that no one had treated it as urgent.
Pregnancy is not neutral for a stenotic mitral valve. The physiologic rise in blood volume and cardiac output that a normal heart accommodates easily becomes, across a fixed valve orifice, a rising pressure gradient the left atrium has to push against — and her valve area, 1.7 cm² three years ago, now measures 1.3 cm² — across the 1.5 cm² line that defines severe mitral stenosis — alongside new exertional dyspnea and early signs of pulmonary congestion on exam that weren't there at her last pregnancy. She is far enough along that the fetus is viable if delivery became necessary, and far enough along that any procedure carries real, if now better-characterized, radiation exposure to consider. The question in front of her team is whether careful medical management can get her safely to delivery, or whether her valve has crossed a threshold where intervening now, mid-pregnancy, is the safer path for both her and the pregnancy she's trying to carry to term.
In the maternal-cardiac clinic, 24 weeks
Rate control is doing real work here, and I want to make sure it's actually maximized before we talk about anything procedural. Tachycardia shortens diastolic filling time, which is exactly what a stenotic mitral valve can least afford — every beat that comes faster gives the left atrium less time to empty across a fixed, narrowed orifice. She is on 25 mg twice daily, which has room to increase — getting her resting heart rate lower may buy real symptomatic ground without any procedural exposure at all.
If her valve area were still in the moderate range, or if she had no symptoms, I wouldn't be raising valvuloplasty as a live option at all — this conversation exists because her anatomy has crossed into severe territory during the pregnancy itself, not because intervention is a routine consideration for mitral stenosis in pregnancy generally.
I want to be direct about the fetal side of this. Percutaneous balloon valvuloplasty during pregnancy, done after 20 weeks in an experienced center with abdominal shielding, carries fetal radiation exposure that's real but has been characterized in enough case series now to say it's generally low with modern technique. That's different from saying it's zero, and different from saying it should be the default. My concern is less about the procedure itself and more about what happens if medical management alone lets her pulmonary pressures keep climbing — decompensated heart failure late in pregnancy is a worse outcome for both her and the fetus than a well-timed procedure earlier.
I agree rate control should be pushed as far as it reasonably goes first — my point isn't to skip that step, it's that if her symptoms and echo findings are still worsening despite a genuine trial of optimized medical therapy, we shouldn't wait until she's in overt heart failure to reconsider valvuloplasty. The window where intervention is safest for the fetus is a real, finite window, not something we get back if we wait too long.
On the medical-therapy side specifically: her metoprolol can be titrated further from 25 mg twice daily — it is beta-1 selective, which is what we want in pregnancy, and unlike atenolol it does not carry the fetal growth-restriction signal — and cautious diuresis is reasonable if pulmonary congestion progresses, though it needs to be conservative given the risk of reducing preload too far in a stenotic valve that depends on adequate left atrial filling pressure to maintain cardiac output. I'd set a defined interval — two weeks — to reassess her symptoms and repeat echo findings on optimized rate control before either declaring medical management sufficient or moving toward valvuloplasty, rather than letting either decision happen by drift.
Agreed: metoprolol titrated further, cautious as-needed diuresis for congestion, and a two-week follow-up with repeat echocardiogram to reassess before deciding on valvuloplasty.
Medical management continues through the remainder of the pregnancy, with close monitoring rather than a procedural plan.
Balloon valvuloplasty proceeds while she is still comfortably within the window considered lowest-risk for the fetus.
MFM will follow fetal growth in parallel throughout, regardless of which branch her cardiac course takes.